JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -99.8% | 2 | -99.2% | 0.00% | – |
| Q3 2022 | $1,000 | – | 237 | +507.7% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 39 | -100.0% | 0.00% | -100.0% |
| Q3 2021 | $1,232,000 | -67.1% | 165,863 | -69.9% | 0.00% | -50.0% |
| Q2 2021 | $3,744,000 | -27.7% | 550,562 | +9.1% | 0.00% | -33.3% |
| Q1 2021 | $5,182,000 | +5594.5% | 504,583 | +4152.0% | 0.00% | – |
| Q2 2018 | $91,000 | -71.7% | 11,867 | -17.1% | 0.00% | – |
| Q1 2018 | $321,000 | +93.4% | 14,317 | +34.4% | 0.00% | – |
| Q3 2017 | $166,000 | – | 10,656 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 10,230,349 | $89,311,000 | 92.14% |
| TRV GP III, LLC | 3,048,780 | $26,616,000 | 11.75% |
| Omega Fund Management, LLC | 529,965 | $4,627,000 | 1.47% |
| Alambic Investment Management, L.P. | 29,536 | $258,000 | 0.22% |
| EAM Investors, LLC | 85,658 | $748,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 108,204 | $945,000 | 0.12% |
| HighVista Strategies LLC | 10,700 | $93,000 | 0.07% |
| CAXTON ASSOCIATES LP | 56,029 | $489,000 | 0.07% |
| ALGERT GLOBAL LLC | 25,310 | $221,000 | 0.07% |
| Granahan Investment Management | 122,282 | $1,068,000 | 0.05% |